Lalistat 1
Lalistat 1 is a potent, selective, and competitive inhibitor of lysosomal acid lipase (LAL) and against purified human LAL (phLAL) with an IC50 of 68 nM. Lalistat 1 is a inhibitor of immunoglobulin A1 protease (IgA1P) proteases for H. influenzae, has less effects on other serine hydrolases (trypsin or β-lactamase, etc.) . Lalistat 1 can be used for the research of niemann-pick type C (NPC) disease[2].
Product Specifications
CAS Number
[501104-16-1]
Product Name Alternative
AM152
UNSPSC
12352005
Hazard Statement
H302, H312, H315, H319, H332, H335
Target
Bacterial; Beta-lactamase
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/lalistat-1.html
Purity
99.75
Solubility
DMSO : 20 mg/mL (ultrasonic; warming)
Smiles
O=C(N1CCOCC1)OC2=NSN=C2N3CCCCC3
Molecular Formula
C12H18N4O3S
Molecular Weight
298.37
Precautions
H302, H312, H315, H319, H332, H335
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
ZNF197 (Zinc Finger Protein 197, pVHL-associated KRAB Domain-containing Protein, Zinc Finger Protein with KRAB and SCAN Domains 9, ZKSCAN9, ZnF20, ZNF166, D3S1363E, P18, VHLaK, ZSCAN41) (MaxLight 490)
